Wealth got close to a $600 million boost as shares of his generics maker, Wockhardt, recovered on rising profits after being hit last year by a U.S. import ban on drugs made at 2 of its factories. An approval from the U.K.'s health regulator partially restored investor confidence. Daughter Zahabiya, who runs the hospital arm, opened a new hospital in Mumbai last December.